Todos Med Ltd (TOMDF)

[redspeed]

Study showed, Nirmatrelvir a 3CL Protease Inhibitor also know as Paxlovid, showed a 25% reduction of Long Covid. Also reduced post covid hospitalizations and death

Nirmatrelvir and the Risk of Post-Acute Sequelae of COVID-19
https://www.medrxiv.org/content/10.1101/2022.11.03.22281783v1

btw: Tollovid and Tollovir also a 3CL Protease Inhibitor, but without that Aids drug that comes with higher risks.

WARNING: This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.